Proprietary, Formulated DNA Plasmid Vaccine Candidate Shows Neutralizing
Activity Against 2 Strains of the COVID-19 Virus
The Goal to Provide Broader Range Protection within a Highly Flexible Platform
Appears to Show Promise
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Proprietary, Formulated DNA Plasmid Vaccine Candidate Shows Neutralizing
Activity Against 2 Strains of the COVID-19 Virus
The Goal to Provide Broader Range Protection within a Highly Flexible Platform
Appears to Show Promise